(Q63229293)
Statements
A Randomized, Double-blinded, Placebo Controlled Study to Evaluate Clinical Efficacy and Safety of Pirfenidone for Skin Fibrosis in Systemic Sclerosis (English)
0 references
May 2017
0 references
April 2019
0 references
72
0 references
18 year
0 references
70 year
0 references